![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||||||||||
Copyright © 2006 Wolski et al; licensee BioMed Central Ltd. Analytical model of peptide mass cluster centres with applications 1School of Mathematics and Statistics, Merz Court, University of Newcastle upon Tyne, NE1 7RU, UK 2Institute for Computer Science, Free University Berlin, Takustr. 9, 14195 Berlin, Germany 3Max Delbrück Center for Molecular Medicine, Robert-Roessle-Str. 10, D-13125 Berlin-Buch, Germany 4Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, D-14195 Berlin, Germany Corresponding author.Witold E Wolski: w.e.wolski/at/ncl.ac.uk; Malcolm Farrow: malcolm.farrow/at/ncl.ac.uk; Anne-Katrin Emde: emde/at/inf.fu-berlin.de; Hans Lehrach: lehrach/at/molgen.mpg.de; Maciej Lalowski: m.lalowski/at/mdc-berlin.de; Knut Reinert: reinert/at/inf.fu-berlin.de Received January 30, 2006; Accepted September 23, 2006. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract Background The elemental composition of peptides results in formation of distinct, equidistantly spaced clusters across the mass range. The property of peptide mass clustering is used to calibrate peptide mass lists, to identify and remove non-peptide peaks and for data reduction. Results We developed an analytical model of the peptide mass cluster centres. Inputs to the model included, the amino acid frequencies in the sequence database, the average length of the proteins in the database, the cleavage specificity of the proteolytic enzyme used and the cleavage probability. We examined the accuracy of our model by comparing it with the model based on an in silico sequence database digest. To identify the crucial parameters we analysed how the cluster centre location depends on the inputs. The distance to the nearest cluster was used to calibrate mass spectrometric peptide peak-lists and to identify non-peptide peaks. Conclusion The model introduced here enables us to predict the location of the peptide mass cluster centres. It explains how the location of the cluster centres depends on the input parameters. Fast and efficient calibration and filtering of non-peptide peaks is achieved by a distance measure suggested by Wool and Smilansky. Background The mass spectrometric (MS) technique is widely used to identify proteins in biological samples [1-4]. The proteins are cleaved into peptides by a residue specific protease, e.g. trypsin. The resulting cleavage products can then be analysed by Peptide Mass Fingerprinting (PMF) [5] or subjected to MS/MS fragment ion analysis [6,7], which both rely on the comparison of peptide or peptide fragment ion spectra with spectra simulated from protein sequence databases [8]. The sensitivity and specificity of the peptide identification can be increased by various post-processing methods, for example calibration [9-12] and identification of non-peptide peaks [10,13,14]. The fact that peptide masses are not uniformly distributed across the mass range but form equidistantly spaced clusters [15] is employed by some of these methods. In dependence on the atomic composition of the peptide, the monoisotopic mass would emerge below (e.g. cystein rich peptides) or above (e.g. lysine rich peptides) the cluster centres. The deviation from the cluster centre is a result of the mass defect, which is the difference between the nominal mass and the monoisotopic mass (Table 1). The mass defect is a result of atom fusion [16,17].
Calibration Mass spectrometric peptide peak-lists of peptide mass finger print experiments [18] can be calibrated by comparing the location of measured peptide masses with the location of the peptide mass cluster centres. Gras et al. [19] suggested the use of maximum likelihood methods in order to determine the calibration coefficients a and b. They defined the likelihood function by: where mi is the i-th mass in the peak-list, and Δm is a search window. P(m, Δm) is the probability to find a mass in [m, m + Δm] given the theoretical distribution of peptide masses. The parameters a, b for argmax ∑i P(ami + b, Δm) can then be used to calibrate the peak-lists. The authors, however, do not provide information on whether P(m, Δm) was determined from the exact distribution of the peptide masses or if a model approximating the distribution was used. They also do not mention which algorithm was used to maximise the likelihood. They reported that a mass measurement accuracy of 0.2Da and better was obtained after calibration. Wool and Smilansky [10] have used Discrete Fourier Transformation (DFT) to determine the frequency λ and phase ϕ of a peak-list or mass spectrum. By comparing the experimental λ and ϕ with the theoretical λ = 1.000495 and ϕ = 0, they determined the slope and intercept of the calibration function. The authors reported a 40 – 60% reduction of the mass measurement error. Furthermore, they presented a scoring scheme for sequence database searches. This scoring scheme approximates the probability P(m, Δm) to observe a peptide peak of mass m with given measurement error Δm. Matrix noise filtration The most widely used MALDI matrices for the analysis of peptides are 3,5-Dimethoxy-4-hydroxycinnamic acid (synapic acid), alpha-Cyano-4-hydroxycinnamic acid (alpha cyano) [20] and 2,5-dihydroxybenzoic acid (DHB) [21]. Unfortunately, clusters of matrix molecules can be ionised and cause peaks in the same mass range where peptide peaks are measured. Matrix aggregate formation can be minimised but not eliminated by adding ammonium acetate [21]. Some of the database search scoring schemes incorporate the number of signals (peaks) not assigned to a protein when computing the identification scores [22]. Therefore, the presence of matrix signals in MS spectra decreases the sensitivity of the MS spectra interpretation. Hence, the removal of peaks strongly deviating from the cluster centres is applied [21,23]. The measure of deviation from cluster centres introduced here provides a simple tool to filter non-peptide peaks. Data reduction A further application which employs the property of peptide mass clustering is the binning of the mass measurement range. By applying this technique the amount of data is reduced, thus increasing the speed with which the pairwise comparison of spectra can be made [24,25]. All these applications require us to know the exact location of or the distance between the peptide mass cluster centres. The distance between the cluster centres, which we will henceforth call wavelength λ, is commonly computed by first generating an in silico digest of the database. Afterwards, the linear dependence between the decimal point and the integer part is determined by regression analysis, for a relatively small mass range of 500 to 1000Da [23]. Various authors report different values of the distance between clusters: Wool and Smilansky reported 1.000495 [10], Gay et al. 1.000455 [15], while Tabb et al. used a wavelength of 1.00057 [24]. In this work we present an analytical model allowing us to predict the mass of the peptide cluster centres. The parameters of the model include: the frequencies of the amino acids in the sequence database [26], the average protein length of the proteins in the database, the cleavage sites of the proteolytic enzyme and the cleavage probability. Based on this model we introduced a measure of deviation of peptide masses from the nearest cluster centre, which is a refinement of a measure proposed by Wool and Smilansky [10]. Using this distance measure, we developed a calibration procedure which employs least squares linear regression in order to determine the affine model of the mass measurement error and subsequently to calibrate the spectra. Using this method we reached higher calibration accuracy as reported by Wool and Smilansky [10], and Gras et al [19]. We used the same distance measure to identify and remove non-peptide peaks prior to database searches performed by the Mascot search engine [22]. Results and discussion A simple way to predict the peptide mass cluster centres of a protein database Figure Figure11
The first model of this dependence which we examined was m(M) - m(N) = c1·m(N). We fixed the intercept at 0, because a hypothetical peptide with a nominal mass of 0 must have a monoisotopic mass equal to 0. The slope coefficient c1, determined by linear regression (cf. Methods) equalled 4.98·10-4(Figure (Figure1,1 We were interested in determining the dependence between monoisotopic and nominal mass analytically. For example, the monoisotopic mass (m(M)) of hypothetical peptides built only of one amino acid i can be predicted, given their nominal mass (m(N)) by where fi is the frequency of the amino acid i in the database. Now write AA fiεi = 0. Therefore, for an amino acid randomly selected from the database, with frequencies fi, the expectation of εi is zero. Now consider a peptide made of a random selection of J amino acids, i(1),...,i(J). The ratio of monoisotopic to nominal mass for this peptide would be:If ∑i εi(j) were uncorrelated with Figure Figure22
When testing for the significance of the intercept coefficient in the regression model mM λmN of a sequence specific (Tryptic) in silico database digest, we found that the intercept coefficient must be included into the model. Therefore, the extended model of the monoisotopic peptide mass cluster centres was:m(M) = c1·m(N) + c0. (3) Subtracting mN from each side of Equation 3 we obtained Δ = m(M) - m(N) = (c1 - 1)·m(N) + c0. The coefficients of the affine linear model of the cluster centres, determined using regression analysis of Δ = m(M) - m(N) on m(N) were c0 = 0.029 and (c1 - 1) = 4.85·10-4. The maximal difference between the prediction of m(M) using m(M) = 1.000499·m(N) and m(M) = 1.000485·m(N) + 0.029 is 0.022 Dalton for m(N) [600, 2500] Dalton.The influence of the digestion enzyme on the wavelength of peptide mass clusters In case of a complete sequence specific cleavage of proteins, the number of generated peptides is CP + 1 peptides, given that CP is the number of cleavage sites per protein. The peptides generated from the terminus of the protein (further called terminal) will not bear a cleavage site residue RC at their end. All the other peptides, which we call internal, will have such a residue at their end. The fraction of the internal peptides fc,n is given by where n is the number of missed cleavages per protein. We approximate CP, for a sequence database, by: where where
In the case of internal peptides, the average contribution of the amino acid residues to the peptide mass is the weighted sum: where is the average mass of non cleavage residues, and: is the average mass of the cleavage site residues RC. Finally, the wavelength of internal peptides is presented as: The wavelength of terminal peptides was determined by: The wavelength λ of all peptides at a mass m with exactly n missed cleavages is given by: where is the weighted sum of the mass of the terminal peptides (with frequency 1 - fc,n) and the internal peptides (with frequency fc,n). Cleavage probability pc In practice, the cleavage probability will depend on various factors, for example on the incubation time and the efficiency of the protease used. The probability to generate a peptide with n 0...∞ missed cleavage sites, given the cleavage probability pc can be modelled using the geometric distribution:P(n, pc) = (1 - pc)n·pc (17) Furthermore, holds. Hence, given the cleavage probability is pcand cleavage residues RC, we express the peptide mass by: where Sn = (fc,nfm,n + fm,(n-1) - fc,nfm,(n-1)). (20) Therefore, the wavelength λ of peptides if the cleavage probability is pc is given by: The monoisotopic mass as a function of the nominal mass can be expressed by: This equation represents our final model of the peptide mass cluster centres. To illustrate the accuracy of the prediction we computed the residuals Δ between the monoisotopic masses of the in silico database digest and the cluster centres predicted by Equation 24. Figure Figure33
Figure Figure4,4 m(N) is approximately a straight line for the mass range greater than 500Da. By using the predicted monoisotopic mass m(M) at m(N) = 500 and at m(N) = 3000 we determined the slope:
and intercept coefficient These coefficients are in good agreement with the slope and intercept determined by linear regression for the in silico sequence database digest (Figure (Figure11 Furthermore, we observed that the intercept c0 will be positive if Figure Figure4,4 (500, 4000) where peptide masses for peptide mass fingerprinting are acquired this difference is minimal.The coefficients c0 and c1 do not depend on the mass of the peptides. Due to this feature, we are going to use the affine model c1m(N) + c0 to predict the peptide mass cluster centres in the applications discussed later. This simplified model is also in agreement with the affine model (Equation 3), which has been fitted by linear regression to the in silico database digest in order to explain the dependency of the peptide mass cluster centres on the nominal mass. Error of the model Combinatorial restrictions may cause significant differences between the linear prediction of the model (Equation 24) introduced and the actual location of the cluster centre. To asses this error we first computed the location of the cluster centres (average of all monoisotopic masses in cluster) of the in silico database digest, and afterwards determined the difference to the cluster centre location predicted by model of Equation 24. This difference
For a moving window of 100Da we computed the maximum and minimum (orange), third and first quartile (red), median (blue) and mean(gree) of The type of distribution around the cluster centres In order to remove non-peptide peaks prior to database search, filtering thresholds have to be chosen. In Figure Figure33 The standard deviation of Δppm(m) is symmetric and does not change for m > 1500. We were interested to determine the distribution of Δppm around the peptide mass cluster centres. To determine the type of distribution we use qqplots [28] shown in Figure Figure6.6 (500 – 530), m (1000 – 1110), m (2000 – 2200) and m (3400 – 3700)) with the normal distribution and t-distributions with various degrees of freedom. The t-distribution with degrees of freedom μ (15, 25) is a good approximation of the empirical distribution of Δppm for masses > 2000,.
Sensitivity analysis The input parameters to the model of the peptide mass cluster centres included: • fi – frequencies of the amino acids. • cleavage specificity of the protease RC • |P| – Protein length • pc – cleavage probability To examine how the output of the model is influenced by these factors we varied the protein length |P| in steps of 100 from 300 to 800 amino acids per protein. We determined the amino acid frequencies fi for 9 sequence databases (cf. Methods) and used them as inputs to the model. Furthermore, six cleavage specificities (shown in Table 3) were examined and the cleavage probability pc was changed from 0.4 to 1 in increments of 0.2.
The box-plots, of Figure Figure7,7
A measure of distance to cluster centres Given an experimentally determined mM we were interested to estimate the deviation Δ from the closest predicted cluster centre. The model of the monoisotopic mass is: c0 + c1·mN + Δ = mM, (28) where c0, c1 can be obtained using the Equations 27 and 26, mN is the nominal mass (an integer). Therefore, for a given mM, c0 and c1 we can determine the deviation Δ from the closest cluster centre of smaller mass by using the modulo operator as suggested by Wool and Smilansky [10]: (mM - c0)(modc1) = (c1·m + Δ)(modc1) = Δ. (29) However, in order to determine the distance to the closest cluster centre we considered two cases: The units of Δλ(mi, 0) are in [m/z]. The magenta dot dashed curves in Figure Figure33 Applications Linear regression on peptide mass rule LR/PR The limitations of calibration methods based on the property of peptide mass clustering are a mass accuracy of only 0.2Da, its sensitivity to non-peptide peaks in the spectra, and that it completely fails if the number of peptide peaks in the peak list is small [10,14,19]. Hence, in practice, the method is used to confirm the results of internal calibration only [14,29]. However, the advantage of the calibration methods based on the property of peptide mass clustering, over other calibration methods [12], is that no internal or external calibrants are required in order to calibrate the peptide mass lists. We propose here a novel method for the calibration of PMF data, based on robust linear regression and the distance measure introduced in the Equation 30. To determine the slope of the mass measurement error we computed the deviation from the peptide mass rule for every pair of peak masses (mi, mj) within a peak-list, employing the following equation: Figure Figure88 peak-list, which adhere to the additional constraint that Δd = |mi - mj| <mmax. This constraint is necessary because the measure Δλ is only able to assign deviation smaller than 0.5Da to the correct cluster centre. For large values of Δd, Δλ increases, if c1 ≠ 0 and assignments to wrong clusters may occur. If a systematic dependence of Δλ on Δd is observed it indicates a mass measurement error. We determined the slope
mcorrected = mexperimental·(1 - To determine the intercept coefficient of the mass measurement error we subsequently computed Δλ(mcorrected, 0) (using Equation 30), for all peak-list masses. Figure Figure8,8 The strip charts (Figure (Figure8,8 Filtering of non-peptide peaks using the peptide mass rule Non-peptide peaks can be recognised according to their deviation from the cluster centres. The amino acids that have the most extreme λ values are I, L and K (because of their large fraction of Hydrogen H (1.007825) atoms) and C (Cysteine – because of the heavy sulfur atom S (31.97207)). If we plot the position after the decimal point given by n·(λi - l)(modl) with n , for i = L and i = C, and connect the points for readability purposes by a line (the red and green lines in Figure Figure99
-413[ppm] = (λC - λDB)·106 < ΔΔ(m, 0)·106/m = where λDB = 1.000511 (Equation 2). We used the relative deviation of Δppm from the cluster centre in parts per million instead of using absolute values. Figure Figure33 Figure Figure1010
We studied how the non-peptide peak filtering influences the Probability Based Mascot Score (PBMS) [22]. In theory, for example one cystein rich peptide strongly deviating from the peptide mass rule and with a unique mass in the database digest, if properly assigned is sufficient to identify the protein unambiguously [10]. In case of PBMS, which requires multiple matches to peptide masses, a single match of a unique peptide mass, even if properly assigned, will not give a score indicating reliable identification of the protein. Furthermore, this scoring scheme takes into account the number of non-matching peaks. If many unassigned peaks are observed, the score is decreased and the assignment is interpreted as insignificant. Therefore, the removal of non-peptide peaks should increase the identification sensitivity. Table 4 demonstrates that an increase of 2.5% in the number of identified samples can be obtained by removing all peaks with a distance
We concluded that non-peptide peak filtering increases the sensitivity of protein identification if using the PBMS scoring schema. However, to which extend these results can be reproduced is dependent on the database search algorithm used. Conclusion We introduced here a simple model to predict the cluster centres of peptide masses. The input parameters of the model can be easily determined for the sequence databases. We studied how these parameters influence the location of cluster centres, concluding that the cleavage specificity of the enzyme used for peptide digestion and the cleavage probability are the main factors. The change of the cluster centre location due to changes in average protein length or due to variability of amino acid frequencies among the databases is relatively small. However, our analysis also illustrates that, due to combinatorial constraints, the location of the cluster centres for masses smaller than l000Da can differ from the average location. Based on the model of the peptide mass cluster centres we derived a measure to determine the deviation of an experimental peptide mass from the nearest cluster centre. We used this distance measure to calibrate the peptide peak-lists and to recognise non-peptide peaks. The calibration method, linear regression on peptide rule, is a robust and accurate method to calibrate single peak lists without resorting to internal calibrants. With this method higher calibration precision was obtained in comparison to other calibration methods, which also employ the property of peptide mass clustering. The same distance measure was used to recognise non-peptide peaks and to remove them from the peak-lists. Due to their removal, an increase of the identification rate of up to 2.5% for the PBMS scoring schema was observed. Methods Data sets In this study, we used three data sets generated in different proteome analyses: 1. A bacterial proteome of Rhodopirellula baltica (unpublished data) (1,193 spectra) measured on a Reflex III [31] MALDI-TOF instrument. 2. A mammalian proteome of Mus musclus (1, 882 spectra) measured on an Ultraflex [31] MALDI-TOF instrument. All PMF MS spectra derive from tryptic protein digests of individually excised protein spots. For this purpose, the whole tissue/cell protein extracts of the aforementioned organisms were separated by two-dimensional (2D) gel electrophoresis [33] and visualised with MS compatible Coomassie brilliant blue G250 [32]. The MALDI-TOF MS analysis was performed using a delayed ion extraction and by employing the MALDI AnchorChip ™targets (Bruker Daltonics, Bremen, Germany). Positively charged ions in the m/z range of 700 – 4, 500m/z were recorded. Subsequently, the SNAP algorithm of the XTOF spectrum analysis software (Bruker Daltonics, Bremen, Germany) detected the monoisotopic masses of the measured peptides. The sum of the detected monoisotopic masses constitutes the raw peak-list. Calibration In order to perform filtering of non-peptide peaks the dataset must be calibrated to high mass measurement accuracy. To align the dataset we used a calibration sequence [12] consisting of several calibration procedures. First calibration using external calibration samples was performed in order to remove higher order terms of the mass measurement error [11]. Next, the affine mass measurement error of all samples on the sample support was determined by linear regression on the peptide mass rule introduced here. Subsequently, the thin plate splines were used to model the mass measurement error in dependence of the sample support positions to calibrate the spectra. Finally, the spectra were aligned using a modified spanning tree algorithm [12]. Mascot database search Processed peak-lists were then used for the protein database searches with the Mascot search software (Version 1.8.1) [22], employing a mass accuracy of ± 0.1Da. Methionine oxidation was set as a variable and carbamidomethylation of cysteine residues as fixed modification. We allowed only one missed proteolytic cleavage site in the analysis. Sequence databases We determined the amino acid frequencies of the nine protein sequence databases listed in Table 5. Seven of these databases are organism specific subsets of the NCBI non-redundant protein database [34].
In silico protein digestion The theoretical digestion of the protein databases was done with ProtDigest [35], a command line program taking a protein sequence database file in fasta format and cleavage specificities as input. Other optional input parameters included fixed as well as variable modifications and number of missed cleavages. The output file contains all theoretically resulting peptides with their corresponding masses. Regression analysis The complete tryptic insilico digest of the SwissProt [27] database generated more than 7 million peptides. In order to compute the slope coefficient we were sampling 500 times 10000 monoisotopic and corresponding nominal masses. For each sample we fitted the affine linear model with and without fixed intercept using linear regression. The slope and intercept coefficients in Figure Figure11 Appendix Wool and Smilanskys algorithm Wool and Smilansky [10] use a Discrete Fourier Transform (DFT) to determine the calibration coefficients. The wavelength λ of a peptide peak-list can be determined by convolution. The "time domain" is the peak-list X with masses xi. We computed the amplitude A (Equation 36) for a small range of frequencies (ω ~ f = 1/λ around λtheo. We scanned the range λ λtheo ± 0.0005 in steps of 5·10-7 computing, for each λ, the real part (Equation 35), the imaginary part (Equation 34) and the amplitude A(ω) (Equation 36):f = 1/λ ω = 2πf, (33) The wavelength of the masses in the peak-list is the λ at the maximum of A(ω). The phase for this ω0 = ωmax A(ω) can be determined by: The peak centres are at the line: But they should be on the line: M = λtheo * N. (39) Solving Equation 38 for N and substituting N in the Equation 39 yields the Equation: mcorr = α(mexp - β) = αmexp - αβ, (42) which can be used to correct the masses. This is an affine linear model with two coefficients α and αβ. Abbreviation • PBMS – Probability based Mascot score • DFT – Discrete Fourier Transformation • m/z – mass over charge Authors' contributions WEW developed and implemented the methods described, carried out the analysis and visualised the results. WEW, MF, ML and AKE wrote the manuscript. AKE implemented the sequence digester. All authors contributed to the final version of the manuscript. Acknowledgements I would like to thank the members of Algorithmic Bioinformatics group of Prof. Knut Reinert at the FU-Berlin for valuable discussion, especially Andreas Döring and Dr. Clemens Gröpl. Many thanks also to Dr. Johan Gobom, Dr. Patrick Giavalisco for providing the PMF-MS data and for valuable discussion. This project was partially funded by the National Genome Research Network (NGFN) of the German Ministry for Education and Research (BMBF). References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||||||||||
Curr Opin Biotechnol. 2000 Aug; 11(4):391-5.
[Curr Opin Biotechnol. 2000]Nature. 2003 Mar 13; 422(6928):198-207.
[Nature. 2003]Biol Mass Spectrom. 1993 Jun; 22(6):338-45.
[Biol Mass Spectrom. 1993]Anal Chem. 1987 Nov 1; 59(21):2621-5.
[Anal Chem. 1987]Anal Chem. 1990 May 1; 62(9):882-99.
[Anal Chem. 1990]Proteomics. 2003 Aug; 3(8):1597-610.
[Proteomics. 2003]BMC Bioinformatics. 2005 Aug 15; 6():203.
[BMC Bioinformatics. 2005]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]Proteomics. 2004 Sep; 4(9):2594-601.
[Proteomics. 2004]Anal Bioanal Chem. 2003 Aug; 376(7):1014-22.
[Anal Bioanal Chem. 2003]Curr Biol. 1993 Jun 1; 3(6):327-32.
[Curr Biol. 1993]Electrophoresis. 1999 Dec; 20(18):3535-50.
[Electrophoresis. 1999]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]Anal Chem. 2001 Feb 1; 73(3):434-8.
[Anal Chem. 2001]J Am Soc Mass Spectrom. 2004 Jun; 15(6):803-22.
[J Am Soc Mass Spectrom. 2004]Electrophoresis. 1999 Dec; 20(18):3551-67.
[Electrophoresis. 1999]J Am Soc Mass Spectrom. 2004 Jun; 15(6):803-22.
[J Am Soc Mass Spectrom. 2004]J Am Soc Mass Spectrom. 2003 Sep; 14(9):943-56.
[J Am Soc Mass Spectrom. 2003]Anal Chem. 2003 May 15; 75(10):2470-7.
[Anal Chem. 2003]BMC Bioinformatics. 2005 Nov 30; 6():285.
[BMC Bioinformatics. 2005]J Am Soc Mass Spectrom. 2003 Sep; 14(9):943-56.
[J Am Soc Mass Spectrom. 2003]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]Electrophoresis. 1999 Dec; 20(18):3527-34.
[Electrophoresis. 1999]Anal Chem. 2003 May 15; 75(10):2470-7.
[Anal Chem. 2003]Proteome Sci. 2003 Aug 13; 1(1):5.
[Proteome Sci. 2003]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]Electrophoresis. 1999 Dec; 20(18):3535-50.
[Electrophoresis. 1999]Electrophoresis. 1999 Dec; 20(18):3551-67.
[Electrophoresis. 1999]Nucleic Acids Res. 2005 Jan 1; 33(Database issue):D154-9.
[Nucleic Acids Res. 2005]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]Nucleic Acids Res. 2005 Jan 1; 33(Database issue):D154-9.
[Nucleic Acids Res. 2005]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]Anal Bioanal Chem. 2003 Aug; 376(7):1014-22.
[Anal Bioanal Chem. 2003]Electrophoresis. 1999 Dec; 20(18):3535-50.
[Electrophoresis. 1999]Bioinformatics. 2004 Dec 12; 20(18):3628-35.
[Bioinformatics. 2004]BMC Bioinformatics. 2005 Aug 15; 6():203.
[BMC Bioinformatics. 2005]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]Electrophoresis. 1999 Dec; 20(18):3535-50.
[Electrophoresis. 1999]BMC Bioinformatics. 2005 Aug 15; 6():203.
[BMC Bioinformatics. 2005]BMC Bioinformatics. 2005 Aug 15; 6():203.
[BMC Bioinformatics. 2005]Electrophoresis. 1999 Dec; 20(18):3551-67.
[Electrophoresis. 1999]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]Electrophoresis. 1995 Jun; 16(6):1034-59.
[Electrophoresis. 1995]BMC Bioinformatics. 2005 Aug 15; 6():203.
[BMC Bioinformatics. 2005]Anal Chem. 2002 Aug 1; 74(15):3915-23.
[Anal Chem. 2002]BMC Bioinformatics. 2005 Aug 15; 6():203.
[BMC Bioinformatics. 2005]Electrophoresis. 1999 Dec; 20(18):3551-67.
[Electrophoresis. 1999]Nucleic Acids Res. 2003 Jan 1; 31(1):34-7.
[Nucleic Acids Res. 2003]Nucleic Acids Res. 2005 Jan 1; 33(Database issue):D154-9.
[Nucleic Acids Res. 2005]Proteomics. 2002 Oct; 2(10):1365-73.
[Proteomics. 2002]